Error: Could not add to watchlist. X

Genzyme Corp

+ Watchlist
GENZ:US
Acquired
GENZ:US was acquired by SAN:FP
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.72
Market Cap (USD)
-
Shares Outstanding (m)
263.669
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Genzyme Corporation provides biotechnology products development. The Company focuses on developing therapeutics for rare disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, and diagnostic and predictive testing. Genzyme serves healthcare provider throughout worldwide.
ADDRESS
500 Kendall Street
Cambridge, MA 02142
United States
PHONE
1-617-252-7500
  • David P Meeker
    President/CEO/Exec VP
  • Marc Esteva
    Chief Financial Officer
  • Yoshi Nakamura
    President:Asia Pacific & Japan
  • Frederic Turner
    President:Latin America
  • Tracey L Quarles
    Senior VP/General Counsel
Show More